Because of a risk of strut fracture that could result in death or serious injury, all Bjork-Shiley Convexo-Concave Heart Valves (BSCC) were removed from the market by the manufacturer. Approximately 86,000 of these heart valves were implanted in patients worldwide. Under a class action settlement agreement in the Bowling, et al. v. Pfizer Inc., et al. heart valve litigation, financial benefits are still available to certain patients implanted with the BSCC heart valve.

A Supervisory Panel of experts funded by the Bowling Settlement has determined that risk of fracture depends on the patient's age, gender, valve size, valve implant position, and certain valve manufacturing characteristics. It is important for people with BSCC heart valves to contact a cardiologist to discuss whether they are at an increased risk of fracture or possibly a candidate for a valve replacement.

If you have a Bjork-Shiley Convexo-Concave Heart Valve, you are urged to register your name and address with the court-appointed Bowling Settlement Claims Administrator.

Only if you register will the Claims Administrator be able to contact you with information about your class action settlement benefits. There is no cost or obligation incurred by registering.

Bowling Claims Administration
bowling-pfizer